COLON-CANCER WITH METASTASIS TO THE OVARY AT TIME OF INITIAL DIAGNOSIS

Citation
Be. Miller et al., COLON-CANCER WITH METASTASIS TO THE OVARY AT TIME OF INITIAL DIAGNOSIS, Gynecologic oncology, 66(3), 1997, pp. 368-371
Citations number
18
Categorie Soggetti
Oncology,"Obsetric & Gynecology
Journal title
ISSN journal
00908258
Volume
66
Issue
3
Year of publication
1997
Pages
368 - 371
Database
ISI
SICI code
0090-8258(1997)66:3<368:CWMTTO>2.0.ZU;2-J
Abstract
Colon cancer with a synchronous ovarian metastasis is occasionally dia gnosed at the time of laparotomy for a pelvic mass. The purpose of thi s retrospective study is to evaluate the clinical presentation as well as the impact of the type of metastatic spread and surgical intervent ion on overall survival. We reviewed charts of 23 patients treated bet ween 1980 and 1995. Pain was the initial symptom in 14 patients (61%), with only four patients (17%) complaining of rectal bleeding, but wit h five patients (22%) complaining of uterine bleeding. At the time of laparotomy, the ovarian capsule was intact in 12 patients. Metastatic disease to the peritoneum was seen in seven patients and to the liver in six patients. On pathological evaluation, the median ovarian tumor size was 10 cm, significantly larger than the median colon tumor size of 4.5 cm. Surgical treatment consisted of colon resection in all but one patient, bilateral or unilateral salpingo-oophorectomy in 22 patie nts, and hysterectomy in nine patients. Only one patient survived 5 ye ars. Sixteen patients died of colon cancer. The median survival time w as 17.8 months, ranging from 1 to 86 months. Tumor size was of no prog nostic importance. Median survival time of patients with peritoneal di sease (10.8 months) was significantly shorter compared to patients wit hout peritoneal disease (25.2 months). In the presence of liver metast asis, the median survival time was, likewise, significantly reduced fr om 20.1 months to 8.1 months. In conclusion, macroscopic metastatic di sease to the ovary is a poor prognostic factor in colon cancer. In sel ected patients who can be rendered disease-free by surgery, prolonged survival is possible and an aggressive approach is recommended. Surviv al of patients with peritoneal disease or liver metastasis is short an d a mainly palliative approach is recommended. (C) 1997 Academic Press .